The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 2020

Filed:

Dec. 14, 2017
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventor:

Maurizio Zanetti, La Jolla, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/04 (2006.01); C12F 3/04 (2006.01); C12N 1/20 (2006.01); A61K 48/00 (2006.01); A61K 9/127 (2006.01); C12N 15/85 (2006.01); A61P 35/00 (2006.01); C12N 5/0781 (2010.01); A61K 9/51 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 35/17 (2015.01); A61K 9/50 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 9/127 (2013.01); A61K 9/5176 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); A61P 35/00 (2018.01); C12N 5/0635 (2013.01); C12N 15/85 (2013.01); A61K 9/5068 (2013.01); A61K 35/17 (2013.01); C12N 2510/00 (2013.01);
Abstract

Provided are engineered B lymphocytes modified to express one or several different types of microRNAs or anti-miRs where in one embodiments the lymphocytes contain multiple copy numbers of nucleic acids encoding the one or several different types of miRs or anti-miRs. Provided are compositions and methods for treating, ameliorating, or preventing a cancer cell, a breast cancer cell or a triple negative breast cancer, or a breast cancer cell that tests negative for estrogen receptors, progesterone receptors, or HER2, comprising or by administering a composition, formulation or pharmaceutical composition comprising a microRNA or anti-miR. Provided are methods for treating an inflammation, a disease, a condition, infection or cancer capable of being treated by modulation or inhibition or expression of an miRNA or anti-miRs by administering to an individual in need thereof a B lymphocyte that secretes a microRNA or anti-miR, or a B lymphocyte supernatant, extracellular vesicle or exosome having a microRNA or anti-miR.


Find Patent Forward Citations

Loading…